Atom Bioworks Inc

CARY, NC · Medtech · Private

Algorithmically-designed DNA biosensor for rapid virus diagnostics that detects pathogen surface protein patterns and generates results within minutes

Grants
$3.4M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: COVID-19 Rapid Sensing Using Structural DNA Biosensor$248,368
Federal grantDepartment of Health and Human Services · Phase II · Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample$1,707,963
Federal grantNational Science Foundation · Phase II · SBIR Phase II:COVID-19 Rapid Sensing Using Structural DNA Biosensors$998,507
Federal grantDepartment of Health and Human Services · Phase II · Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample$450,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1764WICKED SHEETS, LLC—$1.4M
1765IHNNOVA LLC——
1766NEVA ELECTROMAGNETICS, LLC——
1767Atom Bioworks Inc——
1768LI-COR BIOSCIENCES, INC.——
1769AVIV BIOMEDICAL, INC.——
1770YENOS ANALYTICAL, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Multispecific Polynucleotide Nanostructures For Cancer Detection And Therapyapplication
  • Multispecific Polynucleotide Nanostructures For Cancer Detection And Therapyapplication
  • Multispecific Polynucleotide Nanostructures for Cancer Detection and Therapyapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.